Literature DB >> 20813187

P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells.

Zhan-Guo Gao1, Yi Ding, Kenneth A Jacobson.   

Abstract

Extracellular ADP is known to play many important physiological roles. In this study, we identified the P2Y(13) receptor in a rat mast cell line (RBL-2H3) and explored the functional role of ADP, its endogenous agonist. ADP induced both intracellular calcium mobilization and release of hexosaminidase (Hex). In an assay of intracellular calcium, ADP was 100-fold less potent than and equally efficacious as the P2Y(1) receptor-selective agonist MRS2365. However, ADP was more potent and efficacious than MRS2365 in inducing Hex release and in enhancing antigen-induced Hex release. ADP-induced intracellular calcium mobilization was blocked by phospholipase C inhibitor U73122 and by P2Y(1) receptor-selective antagonist MRS2500, but not by pertussis toxin (PTX), suggesting a mechanism mediated by the G(q)-coupled P2Y(1) receptor, but not P2Y(13) (G(i)-coupled) or P2X receptors. ADP-induced Hex release was blocked by PTX and a selective P2Y(13) receptor antagonist MRS2211, but not by MRS2500 or P2Y(1) receptor-specific siRNA, suggesting a G(i)-coupled P2Y(13) receptor-related mechanism. Measurement of gene expression confirmed high expression of both P2Y(1) and P2Y(13) receptors (in comparison to a previously reported P2Y(14) receptor) in RBL-2H3 cells. Thus, we demonstrated that ADP-mediated intracellular calcium mobilization and Hex release in RBL-2H3 cells are via P2Y(1) and P2Y(13) receptors, respectively. Selective antagonists of the P2Y(13) receptor might be novel therapeutic agents for various allergic conditions. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813187      PMCID: PMC2974784          DOI: 10.1016/j.phrs.2010.08.003

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  ATP modulates anti-IgE-induced release of histamine from human lung mast cells.

Authors:  E S Schulman; M C Glaum; T Post; Y Wang; D G Raible; J Mohanty; J H Butterfield; A Pelleg
Journal:  Am J Respir Cell Mol Biol       Date:  1999-03       Impact factor: 6.914

Review 3.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

4.  Extracellular ATP activates mast cells via a mechanism that is different from the activation induced by the cross-linking of Fc receptors.

Authors:  N Sudo; K Tanaka; Y Koga; Y Okumura; C Kubo; K Nomoto
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

5.  Antigen-induced Ca2+ mobilization in RBL-2H3 cells: role of I(1,4,5)P3 and S1P and necessity of I(1,4,5)P3 production.

Authors:  Hyun-Sil Lee; Chang-Shin Park; Young Mi Lee; Ho Young Suk; Tameka C M Clemons; Oksoon Hong Choi
Journal:  Cell Calcium       Date:  2005-10-10       Impact factor: 6.817

6.  Selective expression of potassium channels during mast cell differentiation.

Authors:  M A McCloskey; Y X Qian
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

7.  ATP-induced histamine release is in part related to phospholipase A2-mediated arachidonic acid metabolism in rat peritoneal mast cells.

Authors:  Y H Lee; S J Lee; M H Seo; C J Kim; S S Sim
Journal:  Arch Pharm Res       Date:  2001-12       Impact factor: 4.946

8.  UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.

Authors:  Zhan-Guo Gao; Yi Ding; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2009-11-05       Impact factor: 5.858

9.  Caged agonist of P2Y1 and P2Y12 receptors for light-directed facilitation of platelet aggregation.

Authors:  Zhan-Guo Gao; Béatrice Hechler; Pedro Besada; Christian Gachet; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2007-12-04       Impact factor: 5.858

Review 10.  Targeting human mast cells expressing g-protein-coupled receptors in allergic diseases.

Authors:  Yoshimichi Okayama; Hirohisa Saito; Chisei Ra
Journal:  Allergol Int       Date:  2008-09       Impact factor: 5.836

View more
  12 in total

1.  Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.

Authors:  Qiang Wei; Stefano Costanzi; Qiu-Zhen Liu; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-05-23       Impact factor: 5.858

2.  Role of the ubiquitin-proteasome system in the regulation of P2Y13 receptor expression: impact on hepatic HDL uptake.

Authors:  Véronique Pons; Nizar Serhan; Stéphanie Gayral; Camille Malaval; Michel Nauze; Nicole Malet; Muriel Laffargue; Céline Galés; Laurent O Martinez
Journal:  Cell Mol Life Sci       Date:  2013-09-13       Impact factor: 9.261

Review 3.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

4.  The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells.

Authors:  Zhan-Guo Gao; Qiang Wei; M P Suresh Jayasekara; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2012-07-24       Impact factor: 3.765

5.  Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling.

Authors:  Manuel A R Ferreira; Rick Jansen; Gonneke Willemsen; Brenda Penninx; Lisa M Bain; Cristina T Vicente; Joana A Revez; Melanie C Matheson; Jennie Hui; Joyce Y Tung; Svetlana Baltic; Peter Le Souëf; Grant W Montgomery; Nicholas G Martin; Colin F Robertson; Alan James; Philip J Thompson; Dorret I Boomsma; John L Hopper; David A Hinds; Rhiannon B Werder; Simon Phipps
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

6.  The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss.

Authors:  Ulrikke Voss; Michelle Foldschak Turesson; Bernard Robaye; Jean-Marie Boeynaems; Björn Olde; David Erlinge; Eva Ekblad
Journal:  Purinergic Signal       Date:  2014-02-09       Impact factor: 3.765

Review 7.  Neuroprotection Mediated by P2Y13 Nucleotide Receptors in Neurons.

Authors:  Raquel Pérez-Sen; M José Queipo; Verónica Morente; Felipe Ortega; Esmerilda G Delicado; M Teresa Miras-Portugal
Journal:  Comput Struct Biotechnol J       Date:  2015-02-17       Impact factor: 7.271

Review 8.  Purinergic Signaling in Mast Cell Degranulation and Asthma.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

9.  Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.

Authors:  Edyta Gendaszewska-Darmach; Edyta Węgłowska; Aurelia Walczak-Drzewiecka; Kaja Karaś
Journal:  Oncotarget       Date:  2016-10-25

10.  Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain.

Authors:  Rui Zhou; Tao Xu; XiaoHong Liu; YuanShou Chen; DeYing Kong; Hong Tian; Mingxia Yue; Dujuan Huang; Junwei Zeng
Journal:  J Pain Res       Date:  2018-03-27       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.